Artificial intelligence in ocular medicine

 
Artificial intelligence in ocular medicine: Seeing into the future
In April 2018, the FDA approved the first Artificial Intelligence (AI) enabled device to detect “more than mild diabetic retinopathy.” Globally, additional AI devices have been approved for use in ophthalmic clinics and more are in development. Despite these advances, many clinicians and researchers are unaware of how the technology works, what technology has been approved for clinical use or is in the development pipeline and how to integrate these potential technologies into their research or clinical practice. Researchers face many challenges when developing these algorithms and moving the resulting products from the lab to the clinic.